Aurora Cannabis Inc. (NASDAQ:ACB) Short Interest Up 5.9% in January

Aurora Cannabis Inc. (NASDAQ:ACB) saw a large increase in short interest in January. As of January 15th, there was short interest totalling 4,520,000 shares, an increase of 5.9% from the December 31st total of 4,270,000 shares. Currently, 8.3% of the company’s stock are short sold. Based on an average daily volume of 930,400 shares, the short-interest ratio is presently 4.9 days.

Aurora Cannabis Trading Down 4.5 %

NASDAQ ACB opened at $3.65 on Monday. The firm has a market capitalization of $200.24 million, a PE ratio of -4.80 and a beta of 1.86. The business’s 50-day moving average price is $4.23 and its two-hundred day moving average price is $5.19. The company has a current ratio of 3.83, a quick ratio of 1.88 and a debt-to-equity ratio of 0.07. Aurora Cannabis has a 12 month low of $2.84 and a 12 month high of $9.35.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in ACB. Cubist Systematic Strategies LLC purchased a new position in Aurora Cannabis in the 2nd quarter valued at approximately $50,000. Mackenzie Financial Corp purchased a new position in Aurora Cannabis in the 2nd quarter worth approximately $113,000. Finally, Tidal Investments LLC increased its stake in Aurora Cannabis by 2.7% in the third quarter. Tidal Investments LLC now owns 1,344,321 shares of the company’s stock valued at $7,905,000 after acquiring an additional 34,988 shares during the last quarter. 47.63% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of brokerages have recently issued reports on ACB. TD Cowen started coverage on Aurora Cannabis in a report on Wednesday, December 11th. They set a “buy” rating for the company. TD Securities upgraded shares of Aurora Cannabis to a “strong-buy” rating in a research report on Thursday, December 12th.

About Aurora Cannabis

Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.